Keebeck Alpha, LP Chroma Dex Corp. Transaction History

Keebeck Alpha, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$2.02 - $3.92 $30,027 - $58,270	-14,865 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$3.74 - $6.7 $55,595 - $99,595	14,865 New	14,865 $56,000
Q3 2021 Nov 09, 2021	SELL	$6.05 - $10.41 $127,467 - $219,328	-21,069 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$6.66 - $10.92 $68,804 - $112,814	10,331 Added 96.21%	21,069 $208,000
Q1 2021 May 05, 2021	BUY	$4.59 - $18.74 $49,287 - $201,230	10,738 New	10,738 $100,000
Q4 2020 Feb 05, 2021	SELL	$3.93 - $5.5 $41,485 - $58,058	-10,556 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$4.01 - $5.56 $42,329 - $58,691	10,556 New	10,556 $42,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $372M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.